About the Pancreatic Cancer Session
Pancreatic cancer remains one of the most challenging malignancies to treat, with a high mortality rate and limited therapeutic options. However, recent advancements in cancer research offer hope for improved outcomes. Targeted therapies, immunotherapy, and precision medicine approaches are being investigated to tackle the complex nature of pancreatic tumors. Novel biomarkers are being identified to aid in early detection and personalized treatment strategies. Additionally, advancements in imaging techniques such as MRI and PET scans enable more accurate staging and monitoring of the disease. Clinical trials are actively exploring innovative treatments, including combination therapies and gene therapies, to enhance survival rates and quality of life for pancreatic cancer patients. Despite the formidable obstacles, ongoing research efforts promise to revolutionize the management of this devastating disease.
Topics Covered in Pancreatic Cancer
Precursor Lesions
KRAS Signaling
Early Detection
Surgical Resection
Neoadjuvant Therapy
Cancer Cachexia
Related Scientific Sessions at CIOC 2027
Why Attend the Pancreatic Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Pancreatic Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Pancreatic Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Pancreatic Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pancreatic Cancer Conference 2027 — FAQs
What is the Pancreatic Cancer track at CIOC 2027?
The Pancreatic Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Pancreatic Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pancreatic Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Pancreatic Cancer are all welcome — whether presenting or attending.
Can I present my research in the Pancreatic Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Pancreatic Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Pancreatic Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.